Chimoney and Corpay Collaborate to Revolutionize Global Payouts: Connecting 130+ Countries with Seamless Payment Solutions |
Globe Newswire |
01/11 |
09:00 |
Gilat Announces New Brand Identity Embracing the Company?s Commitment to the New Space Revolution |
Globe Newswire |
01/11 |
07:37 |
Teen Poetry Collection Offers Seasonal Poems About Love and Living |
Globe Newswire |
01/10 |
11:00 |
Music Licensing, Inc. (OTC: SONG) Announces Strategic Developments and Proposed Changes |
Globe Newswire |
01/10 |
09:07 |
Global Advanced IC Substrate Market Size is Projected to Reach USD 14.2 Billion in 2030, Growing at a CAGR of 6.98%: Straits Research |
Globe Newswire |
01/10 |
08:00 |
Akoustis Receives Wi-Fi 7 Design Win from Tier-1 Enterprise Wi-Fi AP Provider |
Globe Newswire |
01/10 |
07:00 |
AvidXchange Announces Timing of Its Fourth Quarter 2023 Financial Results Conference Call and Webcast |
Globe Newswire |
01/09 |
16:05 |
Cronos Enters Australian Cannabis Market |
Globe Newswire |
01/09 |
07:00 |
USAN Approves Generic Name ?Ruxoprubart? for NM8074, an Antibody Therapy focused on Complement-Mediated Diseases |
Globe Newswire |
01/08 |
08:30 |
Spero Therapeutics Provides Corporate Update and 2024 Outlook |
Globe Newswire |
01/05 |
08:05 |
Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma |
Globe Newswire |
01/04 |
16:15 |
AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson?s disease meets primary endpoint |
Globe Newswire |
01/04 |
02:30 |
Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial?Evaluating Tebipenem HBr in Complicated Urinary Tract Infections |
Globe Newswire |
01/02 |
08:05 |
New to The Street Leadership Series Announces Its Interviews of Two Business Leaders, Matt Higgins and Ray Titus; Show Airs on Bloomberg TV as Sponsored Programming on Saturday, December 30, 2023, at 6:30 PM ET |
Globe Newswire |
12/29 |
09:30 |
BiggerPockets Podcast Network Moves to Cumulus |
Globe Newswire |
12/21 |
10:06 |
2024 Economic Outlook Forecasts 2.2% Expansion in Equipment and Software Investment, 1.7% GDP Growth |
Globe Newswire |
12/20 |
08:00 |
Quadient integrates with Xero to automate and streamline accounting for small and medium enterprises |
Globe Newswire |
12/19 |
11:45 |
Akoustis Receives Wi-Fi 6E Design Win from Tier-1 Consumer AP Customer |
Globe Newswire |
12/18 |
07:00 |
LPL Financial Earns WELL Health-Safety Rating for Three Home Office Locations |
Globe Newswire |
12/14 |
09:00 |
Exela Technologies Named in Forrester?s ?The Accounts Payable Invoice Automation Landscape, Q1 2024 Report? |
Globe Newswire |
12/11 |
10:02 |
Centessa Pharmaceuticals Announces New Data from an Additional 52-Weeks of Continuous Treatment from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia |
Globe Newswire |
12/10 |
12:05 |
Cumulus Media?s Westwood One Presents Exclusive National Audio Coverage of the 124th Army-Navy Football Game |
Globe Newswire |
12/07 |
17:17 |
MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial |
Globe Newswire |
12/07 |
07:00 |
Dan Bongino Extends Contract With Westwood One, Recommits to Broadcast Radio |
Globe Newswire |
12/06 |
15:15 |
MONTR?AL EN LUMI?RE 2024 |
Globe Newswire |
12/05 |
11:30 |